Actionability of unanticipated monogenic disease risks in newborn genomic screening: Findings from the BabySeq Project. Green RC, Shah N, Genetti CA, et al. Actionability of unanticipated monogenic disease risks in newborn genomic screening: Findings from the BabySeq Project. American journal of human genetics. 2023. doi:10.1016/j.ajhg.2023.05.007 Read more